- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03340428
Post-release Retention in HIV Care for Ex-inmates in South Africa
Corrections2Community: Post-release Retention in HIV Care for Ex-inmates in South Africa
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
To pilot a randomized clinical trial (RCT) of a transition adherence club (TCAC) versus traditional care, among ex-inmates receiving antiretroviral therapy in South Africa, to study feasibility, acceptability, and preliminary effectiveness using mixed methods.
Investigators will pilot an RCT of the TCAC compared to traditional care among inmates/ex-inmates measuring transition in care, six-month viral load suppression, and follow-up of participants. Feasibility will be assessed by process measures. Acceptability will be assessed using in-depth interviews among 36 participants and 10 staff. Effectiveness will be assessed by a difference in proportions in-care with an undetectable viral load at 6 months and difference in bonding social capital and care satisfaction between arms.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pretoria
-
Pretoria West, Pretoria, South Africa, 0001
- Department of Correctional Services
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Currently incarcerated (either an offender/sentenced inmates or awaiting trial inmate/remandee)
- Housed at one of the study correctional facilities (including participating satellite centres)
- Diagnosed with HIV
- Currently receiving antiretroviral therapy
- Anticipated release or trial date within 3 months of study enrollment
- Self-report expected to reside within Ekurhuleni, Tshwane, or Johannesburg districts of Gauteng Province and within proximity to one of the TCAC sites (within 20 km, 45 minute travel time, or two local taxi minibus rides)
- Agree to post-discharge follow-up
- Medically stable based on DCS health assessment (including not pregnant)
- On antiretroviral therapy (ART) for >3 months at the expected time of corrections release
Exclusion Criteria:
- Failure to provide informed consent to be followed up by study staff after release
- Unable to speak one of the study languages (English, Sesotho, isiXhosa, isiZulu, Setswana, Xitsonga, and Afrikaans)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Transition Community Adherence Club (TCAC)
Participants in this arm will be referred to join a facilitated group setting for HIV on release from incarceration.
This arm will provide HIV care services in a facilitated group setting to provide medical and psychosocial needs of participants.
|
A behavioral intervention targeting stigma and care challenges through care delivery, social capital through a group setting, improved job prospects through referrals and training, and substance use through referrals.
Participants assigned to this group will meet at least every month in a group of 5-15 members for approximately 2 hours.
During the meeting there will be facilitated group discussion, an interactive curriculum including life skills, economic skills, HIV and health, and disclosure and stigma.
Individual health screening and distribution of prepackaged medications conclude the session.
Individual referrals for specific services (e.g.
mental health or substance use management) will be available.
Other Names:
|
No Intervention: Care as usual (CAU)
Care as usual participants will be referred to routine clinic HIV care on release from corrections.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants in Care at Six Months
Time Frame: 6 months after corrections release
|
Self-reported in TCAC or routine DoH clinical care
|
6 months after corrections release
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of Participants Verified in Care at Six Months
Time Frame: 6 months after corrections release
|
Clinical record (electronic or paper) verified in care
|
6 months after corrections release
|
Time to Linkage to HIV Care
Time Frame: 6 months after corrections release
|
Number of days from end of intervention to first clinic visit
|
6 months after corrections release
|
Proportion of Participants Linked to Care Within 90 Days of Corrections Release
Time Frame: 90 days after corrections release
|
Self-reported in TCAC or DoH clinical care
|
90 days after corrections release
|
Viral Suppression (HIV RNA <400 c/mL) at Six Months
Time Frame: 6 months after corrections release
|
Viral load data at 6 months will be based on routinely collected viral load data (clinic records and the electronic National Health Laboratory System to determine 6 month viral load outcomes, successfully applied in prior studies) augmented by viral loads obtained by the study when 6 month viral load data are not available.
|
6 months after corrections release
|
Difference in Bonding Social Capital Score at Six Months
Time Frame: 6 months after corrections release
|
Assessed using a 12-item scale with a higher score indicating greater bonding social capital.
The median scores will be compared.
Range 0-48.
|
6 months after corrections release
|
Difference in HIV Stigma Index Score at Six Months
Time Frame: 6 months after corrections release
|
Assessed using 28-item Berger stigma scale with median score used per stigma construct (internalized, anticipated, experienced).
Higher values indicate more stigma.
Ranges: experienced 38; anticipated 6; internalized 6.
|
6 months after corrections release
|
Proportion of Participants Employed or Self-employed
Time Frame: 6 months after corrections release
|
Self-reported employment
|
6 months after corrections release
|
Feasibility of Implementation of Transition Community Adherence Clubs Per Protocol (Composite Score)
Time Frame: 6 months after corrections release
|
Feasibility of implementation will be assessed based on the proportion of participants meeting the following intervention milestones: TCAC visit, 6-month social capital questionnaire and stigma scale, and 6-month viral load ascertainment.
The proportion of participants in the intervention arm who have completed all of these components with by used as a composite score (range 0-1)
|
6 months after corrections release
|
Acceptability of Transition Community Adherence Clubs
Time Frame: 6 months after corrections release
|
Qualitative outcome assessed using in-depth interviews exploring participant views on the acceptability of the transition community adherence clubs.
This is a qualitative analysis based on thematic coding.
|
6 months after corrections release
|
Difference in Ex-inmate Stigma Index Score at Six Months
Time Frame: 6 months after corrections release
|
Assessed using 28-item hybrid (study specific) stigma scale with median score used per stigma construct (internalized, anticipated, experienced).
Higher values indicate more stigma.
Higher values indicate more stigma.
Ranges: experienced 38; anticipated 6; internalized 6.
|
6 months after corrections release
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB00181117
- 1R34MH115777 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hiv
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CDC FoundationGilead SciencesUnknownHIV Preexposure Prophylaxis | HIV ChemoprophylaxisUnited States
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingHIV Prevention | HIV Preexposure Prophylaxis | ImplementationKenya
-
University of Maryland, BaltimoreWithdrawnHiv | Kidney Transplant | HIV Reservoir | CCR5United States
Clinical Trials on Transition Community Adherence Club (TCAC)
-
Foundation for Professional Development (Pty) LtdNational Institute of Mental Health (NIMH); National Institutes of Health (NIH) and other collaboratorsActive, not recruitingPrEP | HIV Prevention | Cost-effectiveness | AdolescenceSouth Africa
-
University of Cape TownMedical Research CouncilCompleted
-
HIV Prevention Trials NetworkCompleted
-
Columbia UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA); YR Gaitonde Centre for AIDS Research...Recruiting
-
Duke UniversityPfizer; Agency for Healthcare Research and Quality (AHRQ)CompletedCardiovascular DiseaseUnited States
-
Harvard School of Public Health (HSPH)Bristol-Myers Squibb; McGill University Health Centre/Research Institute of... and other collaboratorsCompleted